Certara, Inc. (CERT)

Nasdaq Health Care Health Care Technology S&P SmallCap 600
$12.05
-0.13 (-1.07%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Last report (Nov 05)
$0.06 vs $0.05 est.
Surprise +20.0%

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Nov 05, 2026Sep/2026$0.05$0.06+20.0%

Our record of CERT's reports since we began tracking; it grows each quarter.

Latest results, in brief

All CERT 8-K briefs →
Nov 5, 7:09 AM ET

Certara Q3 revenue rises 4% to $94.9 million; software up 11%, narrows 2026 outlook

Positive earnings 2.02

Certara reported third-quarter 2026 revenue of $94.9 million, up 4% from a year earlier, with software revenue up 11% and services revenue down 2%. The net loss from continuing operations narrowed to $3.6 million, and the company narrowed its full-year 2026 revenue growth range to 2% to 3% and updated its adjusted diluted EPS range to $0.31 to $0.34.

  • Q3 2026 revenue $94.9 million vs. $90.9 million in Q3 2025; software revenue $48.8 million (up 11%), services revenue $46.1 million (down 2%)
  • Net loss from continuing operations $3.6 million vs. $4.8 million a year earlier; adjusted EBITDA $30.2 million, up 6%
  • 2026 full-year revenue growth range narrowed to 2% to 3%; adjusted diluted EPS outlook $0.31 to $0.34
  • Grant Peterson appointed Chief Product Officer, effective November 2, 2026
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$94.90M+4.4% $0.04+300.0% $5.59M5.9%
Jun 2026$93.27M+1.0% $-0.36— -$55.27M-59.3%
Mar 2026$106.92M+0.9% $-0.06-300.0% -$8.76M-8.2%
Dec 2025$143.50M+43.0% $-0.04-200.0% -$5.89M-4.1%
Sep 2025$90.89M-4.1% $0.01— $1.52M1.7%
Jun 2025$92.36M-1.0% $-0.01— -$1.97M-2.1%
Mar 2025$106.00M+9.7% $0.03— $4.74M4.5%
Dec 2024$100.36M+14.0% $0.04— $6.58M6.6%

From Certara, Inc.'s 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$418.84M+8.7% $-0.01—-0.4%
FY2024$385.15M+8.7% $-0.08—-3.1%
FY2023$354.34M+5.6% $-0.35-488.9%-15.6%
FY2022$335.64M+17.3% $0.09—4.4%
FY2021$286.10M+17.5% $-0.09—-4.6%

Frequently asked questions

When is Certara's next earnings date?

Certara has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Certara earn last quarter?

For the quarter ended Sep 2026, Certara reported diluted EPS of $0.04 (+300.0% year over year) on revenue of $94.90M (+4.4%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.